Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors
- PMID: 28299742
- PMCID: PMC6485679
- DOI: 10.1007/978-1-4939-6863-3_14
Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors
Abstract
Structure-based virtual screening (SBVS) is a common method for the fast identification of hit structures at the beginning of a medicinal chemistry program in drug discovery. The SBVS, described in this manuscript, is focused on finding small molecule hits that can be further utilized as a starting point for the development of inhibitors of matrix metalloproteinase 13 (MMP-13) via structure-based molecular design. We intended to identify a set of structurally diverse hits, which occupy all subsites (S1'-S3', S2, and S3) centering the zinc containing binding site of MMP-13, by the virtual screening of a chemical library comprising more than ten million commercially available compounds. In total, 23 compounds were found as potential MMP-13 inhibitors using Glide docking followed by the analysis of the structural interaction fingerprints (SIFt) of the docked structures.
Keywords: Docking; Matrix metalloproteinase; Structural interaction fingerprints; Structure-based virtual screening; Zn-chelating inhibitor.
Figures






Similar articles
-
Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.J Biomol Struct Dyn. 2019 Mar;37(4):944-965. doi: 10.1080/07391102.2018.1444510. Epub 2018 Mar 9. J Biomol Struct Dyn. 2019. PMID: 29475408
-
Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors.J Med Chem. 2017 Jul 13;60(13):5816-5825. doi: 10.1021/acs.jmedchem.7b00514. Epub 2017 Jun 27. J Med Chem. 2017. PMID: 28653849 Free PMC article.
-
Virtual Screening on MMP-13 Led to Discovering New Inhibitors Including a Non-Zinc Binding and a Micro Molar One: A Successful Example of Receptor Selection According to Cross-Docking Results for a Flexible Enzyme.Comb Chem High Throughput Screen. 2017;20(8):719-725. doi: 10.2174/1386207320666170816141351. Comb Chem High Throughput Screen. 2017. PMID: 28814230
-
Hsp90 inhibitors and drugs from fragment and virtual screening.Top Curr Chem. 2012;317:61-82. doi: 10.1007/128_2011_181. Top Curr Chem. 2012. PMID: 21647838 Review.
-
Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents.ChemMedChem. 2017 Aug 8;12(15):1157-1168. doi: 10.1002/cmdc.201700349. Epub 2017 Jul 19. ChemMedChem. 2017. PMID: 28722301 Review.
References
-
- Ripphausen P, et al. Quo Vadis, Virtual Screening? A Comprehensive Survey of Prospective Applications. J Med Chem. 2010;53(24):8461–8467. - PubMed
-
- Ghosh S, et al. Structure-based virtual screening of chemical libraries for drug discovery. Curr Opin Chem Bio. 2006;10(3):194–202. - PubMed
-
- Takaishi H, et al. Joint diseases and matrix metalloproteinases: A role for MMP-13. Curr Pharm Biotechnol. 2008;9(1):47–54. - PubMed
-
- Zigrino P, et al. Stromal Expression of MMP-13 is Required for Melanoma Invasion and Metastasis. J Invest Dermatol. 2009;129(11):2686–2693. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources